7. Intensive Care Service Optimization For Covid-19 Pandemic In Almaty City

Authors

  • T. Kuandykov National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • V. Mutagirov National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • E. Abdkereev National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • B. Dostarbaev National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • M. Agzamov National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • E. Voronin National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • A. Akshikeshov National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • T. Bidaibai National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • M. Tolepbergen National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • A. Sharipov National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan

DOI:

https://doi.org/10.35805/BSK2023III007

Downloads

Abstract

Since the beginning of the spread of coronavirus infection in the world, the number of infected has exceeded 102.5 million people, and more than 2.2 million people have died. In Kazakhstan, according to the world statistics of COVID-19, the 59th place in the number of detected cases of COVID-19 and the 68th place in deaths from coronavirus was noted. The vast majority of patients with COVID-19 have a mild or moderate illness, but 5% of those with a critical course of the disease require treatment in an intensive care unit. The length of stay in the intensive care unit averages 10.8 days, however, in 22.7% of patients, the duration of treatment in the ICU exceeds 30 days. In order to improve treatment outcomes, many clinics use a team work methodology that requires a sufficient number of highly qualified medical personnel. However, due to the shortage of personnel in intensive care units, measures are being taken to retrain medical personnel of other specialties. At the same time, short training courses do not always improve the results of treatment in a high quality and lead to a deterioration in the results of most patients.

Keywords

COVID-19 pandemic, critical care, intensive care service organization

References

  1. Gilardino, R.E. Does ‘Flattening the Curve’ Affect Critical Care Services Delivery for COVID-19? A Global Health Perspective. International Journal of Health Policy and Management 9, 12 (2020): 503-507
  2. M. Yang, H. Dong, Zh. Lu. “Role of Anaesthesiologists during the COVID-19 Outbreak in China.” Br J Anaesth 124, 6 (June 2020): 666–669
  3. An algorithm for the interaction of specialists from the Center for Anesthesiology and Intensive Care with doctors of hospitals has been developed and is successfully applied in practice. INTENSIVE CARE SERVICE OPTIMIZATION FOR COVID-19 PANDEMIC IN ALMATY CITY
  4. Blumenthal et al. “Covid-19 – Implications for the Health Care System.” N Engl J Med 383, 15 (2020): 1483-1488
  5. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. “Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) – China.” China CDC Weekly 2, 8 (2020): 113-122
  6. Alqahtani, Jaber S., TemitopeOyelade, Ali M. Aldhahir, Saleh M. Alghamdi, MeshalAlmehmadi, Abdulaziz S. Alqahtani, et al. “Prevalence, Severity and Mortality Associated with COPD and Smoking in Patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.” PLoSOne 15, 5 (2020): e0233147
  7. Tabakokureniei COVID-19. Zayavlenie VOZ ot 11 maya 2020 g. ZHeneva: Vsemirnayaorganizaciyazdravoohraneniya; 2020 (https://www.who.int/ru/ news-room/detail/11-05-2020-who-statement-tobacco-use-and-covid-19, posostoyaniyuna 29 maya 2020 g.)
  8. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020;382:2012-22
  9. Grasselli, G., Zangrillo, A., Zanella, A., et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA (2020). doi:10.1001/jama.2020.5394
  10. Yang, X., Yu, Y., Xu, J., et al. “Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.” Lancet Respiratory Medicine 8 (2020): 475-81
  11. Mitra, A.R., N.A. Fergusson, E. Lloyd-Smith, et al. “Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.” Canadian Medical Association Journal 192, 26 (2020): E694-E701
  12. Phua, J., Weng, L., Ling, L., Egi, M., Lim, C.M., Divatia, J.V., et al. “Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.” Lancet Respiratory Medicine 8, 5 (2020): 506-517
  13. Guan, Wei-jie, Zheng-yi Ni, Yu Hu, Wen-hua Liang, Chun-quanOu, Jian-xing He, et al. “Clinical Characteristics of Coronavirus Disease 2019 in China.” New England Journal of Medicine 382, 18 (2020): 1708-1720
  14. Opytgosudarstv v bor’be s pandemiej COVID-19. Sbornik stranovyh kejsov. Schetnayapalata Rossijskoj Federacii. 2020
  15. National Health Service, Improvement. “Specialty Guides for Patient Management During the Coronavirus Pandemic: Clinical Guide for Renal Replacement Therapy Options in Critical Care During the Coronavirus Pandemic.” England.nhs.uk,
  16. Singh, Anoop K., Rajeev Gupta, and Anoop Misra. “Comorbidities in COVID-19: Outcomes in Hypertensive Cohort and Controversies with Renin Angiotensin System Blockers.” Diabetes Metabolism Syndrome 14, 4 (2020): 283-287
  17. Wu, Chaomin, Xiaoyan Chen, YanpingCai, Jiehua Xia, Xing Zhou, Sheng Xu, et al. “Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China.” JAMA InternalMedicine 180, 7 (2020): 934
  18. The average number of resuscitation patients who were daily in the city hospitals in July was 37.1 patients, of which 24.3% were patients in an extremely serious unstable condition. The main comorbidities were pathologies of the heart, brain, and kidneys. The severe course of pneumonia with coronavirus infection is accompanied by a high mortality rate. The work of the resuscitation service in Almaty was optimized by creating an Anesthesiology and Resuscitation Center for the treatment of critically ill patients with COVID-19. The functioning of the Center leads to an improvement in treatment results, in the form of a significant reduction in mortality, which is confirmed by the odds ratio (OR) = 3.39 and relative risk (RR) = 1.57
  19. Bindom, Susan M., and Eric Lazartigues. “The Sweeter Side of ACE2: Physiological Evidence for a Role in Diabetes.” MolecularandCellularEndocrinology 302, 2 (2009): 193-202
  20. Burke, R. M., Midgley, C. M., Dratch, A., Fenstersheib, M., Haupt, T., Holshue, M., et al. “Active monitoring of persons exposed to patients with confirmed COVID-19 — United States, January–February 2020.” MMWR MorbidityandMor talityWeeklyRepor t (2020)
  21. Huang, R., Xia, J., Chen, Y., Shan, C., Wu, C. “A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China.” Lancet Infectious Diseases 20, no. 5 INTENSIVE CARE SERVICE OPTIMIZATION FOR
  22. Pan, X., Chen, D., Xia, Y., Wu, X., Li, T., Ou, X., et al. “Asymptomatic cases in a family cluster with SARS-CoV-2 infection.” LancetInfectiousDiseases 20, 4 (2020): 410-411
  23. Tong, Z. D., Tang, A., Li, K. F., Li, P., Wang, H. L., Yi, J. P., et al. “Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020.” Emerging Infectious Diseases 26, 5 (2020): 1052-1054
  24. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.” Lancet. 2020;395(10223):497-506
  25. Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., ...& Guan, L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020. 395(10229), 1054-1062

Published

2023-08-10

Issue

No. 3 (2023)

Section

Статьи